ClinicalMetric / Countries / Netherlands / tricuspid regurgitation
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

tricuspid regurgitation Clinical Trials in Netherlands

Active clinical trials for tricuspid regurgitation with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇳🇱 Netherlands

Active Trials in Netherlands (2)

NCT05797519
Recruiting

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Enrollment
120 pts
Country
🇳🇱 Netherlands
VDyne, Inc.
View Trial →
NCT06836011
Recruiting

A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.

Enrollment
600 pts
Country
🇳🇱 Netherlands
Medical University of Vienna
View Trial →

Frequently Asked Questions

How many tricuspid regurgitation clinical trials are active in Netherlands?
There are currently 2 active clinical trials for tricuspid regurgitation with sites in Netherlands, of which 2 are actively recruiting patients.
How can I join a tricuspid regurgitation clinical trial in Netherlands?
To join a tricuspid regurgitation clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are tricuspid regurgitation trials in Netherlands?
Active tricuspid regurgitation trials in Netherlands span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global tricuspid regurgitation Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology